Next Article in Journal
Effects of Bacillus amyloliquefaciens XJ-BV2007 on Growth of Alternaria alternata and Production of Tenuazonic Acid
Next Article in Special Issue
Deliberate Self-Poisoning with Plants in Southeastern France, a Poison Center 20-Year Report
Previous Article in Journal
Identification of Cyanobacteria and Its Potential Toxins in the Joanes I Reservoir, Bahia, Brazil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis

1
Laboratory of Experimental Nephrology, Faculty of Medecine, Université Libre de Bruxelles, 1000 Bruxelles, Belgium
2
Saint-Petersburg Institute of Pharmacy, 197376 Saint Petersburg, Russia
3
Laboratory of Therapeutic Chemistry and Pharmacognosy, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons—UMONS, 7000 Mons, Belgium
4
Department of Technology of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, Prof. Popov 14a, 197376 Saint Petersburg, Russia
5
CMMI Center for Microscopy and Molecular Imaging, 6041 Charleroi, Belgium
*
Author to whom correspondence should be addressed.
Toxins 2023, 15(1), 52; https://doi.org/10.3390/toxins15010052
Submission received: 28 November 2022 / Revised: 30 December 2022 / Accepted: 5 January 2023 / Published: 6 January 2023

Abstract

:
Herbal remedies used in traditional medicine often contain several compounds combined in order to potentiate their own intrinsic properties. However, herbs can sometimes cause serious health troubles. In Belgium, patients who developed severe aristolochic acid nephropathy ingested slimming pills containing root extracts of an Aristolochia species, as well as the bark of Magnolia officinalis. The goal of the study was to evaluate, on a human renal cell line, Aristolochia and Magnolia extracts for their cytotoxicity by a resazurin cell viability assay, and their genotoxicity by immunodetection and quantification of the phosphorylated histone γ-H2AX. The present study also sought to assess the mutagenicity of these extracts, employing an OECD recognized test, the Ames test, using four Salmonella typhimurium strains with and without a microsomial fraction. Based on our results, it has been demonstrated that the Aristolochia–Magnolia combination (aqueous extracts) was more genotoxic to human kidney cells, and that this combination (aqueous and methanolic extracts) was more cytotoxic to human kidney cells after 24 and 48 h. Interestingly, it has also been shown that the Aristolochia–Magnolia combination (aqueous extracts) was mutagenic with a TA98 Salmonella typhimurium strain in the presence of a microsomial liver S9 fraction. This mutagenic effect appears to be dose-dependent.
Key Contribution: Aristolochia and Magnolia are more genotoxic, cytotoxic, and mutagenic when used together than when used separately.

1. Introduction

Following disappointment with allopathic treatments, patients may turn to other therapies such as phytotherapy. Phytotherapy is increasingly considered by the general public as a safe and reliable therapy. Moreover, plant derivatives (such as Magnolia officinalis or herbal medicinal products that contain aristolochic acids) are often readily available either in supermarkets or on the internet, and sometimes the products’ degree of purity is not suitable for pharmaceutical use [1]. For example, mycotoxins, mainly Fusarium toxins, are naturally present in several plants that are widely used as feedstuffs worldwide [2,3]. Although often perceived as innocuous by the general public, many herbs harbor phytochemicals that are either directly reactive towards DNA, or likely to disturb cellular homoeostasis, cell cycle, and/or genome maintenance mechanisms; this may translate into genotoxicity, carcinogenicity, or co-carcinogenicity [4]. When taken orally (in the form of pills, tea, syrup, etc.), plants are excreted by the kidneys. Indeed, the excretory organs, such as the kidney and bladder, are often the sites of toxicity. Moreover, kidney diseases often lead to an increased risk of morbidity from cardiovascular diseases [5,6].
Genotoxicity refers to the deleterious effect of a chemical compound or a physical event on the genetic material; such genotoxic events are considered hallmarks of cancer risk [4].
In the early 1990s, an epidemic of rapidly progressive tubulointerstitial nephritis was reported in young Belgian female patients who inadvertently took slimming pills containing the bark of Magnolia officinalis Rehder & E. H. Wilson, and inadvertently the roots of an Aristolochia species [7,8,9].
At that time, the causative nephrotoxic agent was identified as aristolochic acid (AA), and the renal disease following their ingestion is now worldwide recognized as Aristolochic Acid Nephropathy (AAN) [10,11]. Remarkably, despite the worldwide human consumption of AA, the Materia Medica and Pharmacopoeia before 1995 failed to mention any of the toxic effects of Aristochia spp. [12].
AA was classified as a human carcinogen Class I by the World Health Organization International Agency for Research on Cancer in 2002 [13]. The nephrotoxic effect of aristolochic acid is irreversible. AAN and associated upper urinary tract urothelial carcinoma and bladder cancer may become a major public health threat in the next few years [4,14].
However, despite Aristolochia species prohibition in many countries, more cases of AA intoxication have been reported all over the world, especially in Asia and in Balkan countries [9,15]. For example, there is accumulating evidence that Balkan endemic nephropathy (BEN) is an environmental disease caused by AAs released from the decomposition of Aristolochia clematitis L., an AA-containing weed that grows abundantly in the Balkan Peninsula [16,17].
Nowadays, herbal medicinal products that contain AA continue to be manufactured and marketed worldwide with inadequate regulation, and possible environmental exposure routes receive little attention [1].
In 2015, Nachtergael et al. showed the effect of M. officinalis on Aristolochia genotoxicity. The high potentiation of AA genotoxicity by M. officinalis can be tentatively explained by an increased metabolic activation into aristolactams [18].
As summarized in Table 1, major significant bioactive components isolated from the bark of M. officinalis appear to be the polyphenolic neolignans, magnolol, and honokiol [19,20]. Different tertiary and quaternary alkaloids have also been isolated and structurally elucidated [20], including (i) the aporphine alkaloids N-methylcoxylonine, (S)-magnoflorine, magnofficine, (R)-asimilobine, corytubérine, anonaine, and liriodenine and (ii) benzyltetrahydroisoquinoline alkaloids (R)-magnocurarine, (S)-tembetarine, lotusine, (R)-oblongine, and reticuline [21,22]. Magnoflorine and magnocurarine are considered the major and most potent Magnolia bark alkaloids [23].
In the present study, Magnolia effects in the AAN case were further investigated. Following the nephrotoxicity of AA compounds, studies were performed in HK-2 kidney proximal human tubule cells.
The goal of the present study was to evaluate, on a renal cell line, Aristolochia and Magnolia aqueous and methanolic extracts, alone and in combination, for their cytotoxicity by a resazurine cell viability assay, and their genotoxicity by immunodetection and quantification of the phosphorylated histone γ-H2AX, a genotoxicity biomarker [24,25]. The present study also sought to assess the mutagenicity of these compounds, using an OECD recognized test, the Ames test, using four Salmonella typhimurium strains—TA98, TA100, TA1535, and TA1537—with and without the S9 microsomal fraction, often used to mimic mammal metabolism and to estimate the need for bioactivation [26].

2. Results

2.1. Plant Extract Characterization

2.1.1. Aristolochia baetica L.

The thin-layer chromatography of raw plant material and the aqueous extract of A. baetica was used according to the European Pharmacopoeia 8.4 monograph “Test for aristolochic acids in herbal drugs,” previously detailed by Nachtergael et al. In brief, the following was used: an HPTLC Silica gel 60 plate F254, a mobile phase of anhydrous formic acid, water, ethyl acetate, and toluene (3:3:30:60, v/v/v/v), an upper layer detection method using 100 g/L Tin(II) chloride in diluted hydrochloric acid at 100 °C for 1 min at UV365 nm, as well as aristolochic acid I and II (Rf 0.46 and Rf 0.54) [18].

2.1.2. Magnolia officinalis Rehder & E.H. Wilson

Alkaloid and lignan detection was made using HPTLC-MS. As described by Estevez et al., mass spectrometry can indeed be used to characterize and identify components from toxins [27].

Alkaloids

Following several protocols, the most appropriate mobile phase was selected for the M. officinalis extracts.
Each plate was revealed using a Draggendorff reagent. We found that, following Japanese Pharmacopoeia XVI, the most suitable mobile phase composition was butanol/water/acetic acid (at a proportion of 4/2/1).

Lignans

According to European Pharmacopoeia 8.4, a methanol/ethyl acetate/toluene mobile phase (4/8/120, v/v/v) was used and observed using vanillin reagent.
Both lignans, magnolol and honokiol, and almost 15 different alkaloids were detected in methanolic and aqueous extracts (see Table 1).

2.2. Cytotoxicity of the Plant Extract Alone or in Combination

The cytotoxicity of Aristolochia and Magnolia aqueous and methanol extracts was investigated on HK-2 cells by following resazurin viability curves after 24 and 48 h of exposure to each material alone, or in combination. Results are presented in Figure 1 and Table 2.
One-way ANOVA (Dunnett’s multiple comparison test; p < 0.01; n = 6) confirmed that the viability more significantly decreased with the Magnolia than the Aristolochia extracts, after 24 and 48 h of exposure. The combination of both plant extracts resulted in a more significant deleterious effect on cell viability.

2.3. Genotoxicity throughout γ-H2AX Detection

The measurement of the phosphorylated histone γ-H2AX is increasingly considered as an attractive biomarker for either DNA damage or DNA repair. H2AX is a eukaryotic histone protein that, depending on the organism and cell type, constitutes 2–25% of the mammalian histone H2A. Interestingly, this histone is phosphorylated on its 139th serine residue in the presence of DNA damage, mainly a double-strand break, to yield γ-H2AX. The latter form nuclear domains, named “DNA damage foci”, can be visualized cytologically using fluorescence microscopy [18,24,25]. γ-H2AX detection by immunofluorescence in HK-2 cells demonstrated that treating cells with bleomycin for 24 and 48 h induced an increase in γ-H2AX foci at all tested concentrations: 50, 100, and 200 µg/mL (data not shown). By comparison with these positive controls, cells treated with the aqueous extract at a 1 mg/mL concentration of a AristolochiaMagnolia combination (1:1 ratio) demonstrate an increase in γ-H2AX foci, while the Aristolochia or the Magnolia aqueous extracts used alone did not induce any significant increase in γ-H2AX foci (Figure 2). Cells treated with a combination of Aristolochia and Magnolia aqueous extracts at 0.25 and 0.5 mg/mL did not significantly increase the number of γ-H2AX foci (data not shown).
γ-H2AX fluorescence detection has been quantified by measuring total fluorescence and total fluorescence relative to the number of nuclei. Statistical significance could not be demonstrated for extracts used alone. However, statistical significance could be highlighted by using a combination of the two plants (see Figure 3).
We further investigated which component could explain this increasing genotoxicity. We performed the same experiment with aristolochic acids (I and II), magnolol, honokiol, magnoflorin, and a combination of all of them over 24 h and 48 h exposure. Unfortunately, we did not observe any increase in the presence of γ-H2AX after these different experimental conditions (Figure 4—data not shown for 48 h).

2.4. Genotoxicity and Mutagenicity throughout the Ames Test

An Ames test was run using four strains of histidine-deficient Salmonella typhimurium: TA-100, TA-98, TA-1535, and TA-1537, with and without the S9 fraction. The number of revertants was recorded for each sample and compared to a positive control.
With the TA-100 strain, A. baetica seems to be mutagenic at every concentration from 0.25 mg/mL, without the S9 microsomal fraction. In the presence of the S9 fraction, only the concentration of 10 mg/mL was mutagenic. The TA-1535 strain, on its side, does not seem to be sensitive to Aristolochia or Magnolia extracts (data not shown). A statistically significant increase in the mutagenicity induced by Aristolochia extracts alone, as well as the Aristolochia–Magnolia combination, was found with the strain TA-98, but only with the S9 microsomial liver fraction. The TA-98 strains reveal frameshift mutations, meaning that the genotoxicity is based on a genetic mutation caused by the indels (insertions or deletions) of a number of nucleotides in a DNA sequence. Moreover, this mutagenic effect appears to be dose-dependent (Table 3).

3. Discussion

The bark of M. officinalis Rehder & Wilson, known under the pinyin name “Hou Po,” has been traditionally used in Chinese and Japanese medicines for the treatment of anxiety, asthma, depression, gastrointestinal disorders, and headaches. Many pharmacological activities, including antioxidant, anti-inflammatory, antibiotic, and antispasmodic effects [20], as well as its alleviating effect on depression in postnatal women [28], have been reported for this herb and its major compounds. Many of these activities have been attributed to the lignans magnolol and honokiol, two major constituents of the plant.
In the present in vitro study, we first demonstrated that the M. officinalis aqueous and methanolic extracts show a higher cytotoxicity after 24 and 48 h than the aqueous and methanolic extracts of Aristolochia baetica. Combining both plant extracts resulted in the most deleterious effects.
However, we were not able to identify which component association actually increased the generation of γH2AX foci. Therefore, it seems that lignans (i.e., Magnolol and Honokiol) and the tested alkaloid magnoflorin are not the agents responsible for the increased toxicity of Aristolochia. Considering the characterization of our Magnolia officinalis extracts, we can hypothesize that many other components could be candidates for these effects, mainly alkaloid compounds.
Concerning the mutagenic assessment of our extracts, we performed the Ames test. The Ames test is one of the most frequently applied tests in toxicology [29]. Following the OECD guidelines, almost all new pharmaceutical substances and chemicals used in the industry are tested by this assay [30]. The Ames test, or the so-called Salmonella/microsome test, is widely used in investigating the mutagenic effects of chemicals. Not only is it one of the most reliable short-term bacterial test systems, but it is also cheap and provides results rapidly [31,32]. Each herbal extract was tested on four different strains. TA100 and TA1535 were used to detect base substitution mutations, and TA98 and TA1537 were used to detect frameshift mutations. The liver S9 fraction is useful for imitating the mammalian metabolism that activates pro mutagens [26,31,32,33].
The Salmonella strain TA-98, in the presence of the S9 fraction, showed that the Magnolia and Aristolochia aqueous extract combination is more mutagenic than both aqueous extracts tested separately. This result suggests that the combination generates frameshift mutations and that this effect is dose-dependent. The need for the S9 fraction proves that the combination of plant extracts has to be metabolized by hepatic enzymes to be mutagenic. This pathway is related to the fact that AAN patients ingested root extracts as slimming pills. After oral intake, these pills, following the pharmacokinetic features, were metabolized by the liver before targeting the kidneys where they generated their toxicity.
Although AA might directly cause nephropathy, the enzymatic activation of AAI is required to exert its genotoxic effect. The reduction of the nitro group is now considered to be the major activation pathway of AA [16]. NAD(P)H:quinone oxidoreductase (NQO1) and microsomal enzyme NADPH:cytochrome P450 oxydoreductase are the main enzymes responsible for the metabolic activation of AA in aristolactams by reduction of the nitro group, and they may be involved in the bioactivation of AA, but its exact roles are still a matter of debate [16,34,35,36,37]. Interestingly, in 2013, Cui et al. showed in a mouse model that kidney NQO1 was significantly increased following treatment with an ethanolic extract of Magnolia officinalis bark [38].
It has been recently demonstrated, for the first time, that cell lines deficient in nucleotide excision repair (NER) machinery accumulated higher adduct levels, indicating that NER is the major mechanism responsible for the repair of these lesions [39].
Following our results, the high potentiation of AA genotoxicity by Magnolia officinalis could then be tentatively explained by an increased metabolic activation into aristolactams. More investigations are needed to determine which components could be responsible for the increase in DNA damage.

4. Conclusions

Plants are interesting from a health point of view but can be toxic. Moreover, these toxicities are not always direct but can occur months or years later. This further complicates the identification of the origin of these adverse reactions. This study demonstrated that Magnolia officinalis, often described as safe, seems to be relatively cytotoxic, mainly to kidney cells, but also seems to have antibacterial activity (significantly cytotoxic and mutagenic to Salmonella typhimurium TA-100 strains at 10 mg/mL). Moreover, the genotoxicity to the kidney of the association of Aristolochia baetica and Magnolia officinalis extracts is significantly higher compared to the individual plant extracts. This was also confirmed by an Ames test, an OECD-recommended mutagenicity assessment assay. The high potentiation of AA genotoxicity by M. officinalis could be an explanatory factor for Chinese herb nephropathy cases observed in Belgium in the 1990s. Furthermore, plants are, in most cases, used in combination rather than alone. This study proves that plant combinations can be more toxic under specific conditions.

5. Materials and Methods

5.1. Herbal Extraction

As previously performed by Nachtergael et al. [18], dried Magnolia officinalis Rehder & E. H. Wilson cortices were obtained from Phytax (Schlieren, Switzerland). A certificate of analysis was obtained from the company, indicating a sample free from aflatoxins (detection limit: 0.4 µg/kg) and heavy metals (detection limit: 10 µg/kg). Instead of the Aristolochia fangchi Y. C. Wu ex L. D. Chow & S. M. Hwang from the initial prescription, now prohibited in Belgium, Aristolochia baetica L. radix was used in the present study. It is deposited at the National Herbarium of Morocco (Scientific Institute of Rabat) under the voucher name RAB 78463. Further investigations proved that A. baetica L. also contains quite similar aristolochic acid composition [18]. Each herbal extract has been prepared using polar solvents (water and methanol) (Table 4).
For both aqueous and methanolic extracts, the maximal concentration tested was 1 mg/mL. Plant combinations were assessed in a 1:1 ratio. Indeed, the initial prescription followed the typical formula: 100—200 mg of Stephania (adulterated by the roots of an Aristolochia species, probably A. fangchi), 100–200 mg of Magnolia (bark of Magnolia officinalis Rehder & E. H. Wilson), 2 mg of Belladona dry extract, 45 mg of acetazolamide, 20 mg of fenfluramine, 20 mg of diethylpropion, and 50 mg of meprobamate. The two plants were present in slimming pills at the same concentration, and this is why a 1:1 mixture was selected for use.
The common dosages for Magnolia officinalis and Aristolochia species are 3–9 g and 4.5–9 g, respectively [40]. A study showed that, following a 240 mL dose of water, the intestinal liquid volume ranges from 67 ± 17 to 93 ± 24 mL, respectively, 2 and 45 min after ingestion [41]. The liquid volume is divided into water pockets, where 60% of the total volume is contained in a small number of large pockets (>20 mL), and 40% is contained in a large number of the smallest pockets (0.5–20 mL). Regarding the 100–200 mg of plants ingested in the Belgian cohort patients, the concentration reached in the small intestine can be coarsely estimated at around 100–200 mg/100 mL, or 1–2 mg/mL, for each plant. The concentration used in the present study is in line with the estimated concentration of plants in the small intestine after the ingestion of slimming pills.

5.1.1. Aqueous Extraction

Each material was decocted in water, following the traditional instructions in the Chinese Materia Medica [40]. The decoction was filtered on cellulose 3 times, and the filtrate was lyophilized (Heto PowerDry LL1500, Thermo Fisher Scientific Inc., Waltham, MA, USA) and stored at −20 °C until further use. The extracts were dissolved and diluted with a complete culture medium to the required concentrations.

5.1.2. Methanolic Extraction

Following the Japanese Pharmacopoeia, 13th Edition (1996), each plant was macerated in a known volume of methanol for 24 h in the dark. Plants were mixed with a Polymix PX-MFC 90 D mixer (1.0 mm diameter). The solvent from the resulting mixture was harvested and removed from the extract by the rotary evaporator (Rotavapor R-210, Vacuum pump V-700, Vacuum controller V-850, Heating Bath B-491).

5.2. Extract Characterizations

The raw and lyophilized herbal materials and the methanolic extracts were analyzed by HPTLC thin-layer chromatography according to the European Pharmacopoeia 8.4 monographs “Magnolia officinalis bark” and “Test for aristolochic acids in herbal drugs.” Comparable amounts of raw herbs and extracts (calculated from the lyophilization yield) were applied on HPTLC plates (HPTLC silica gel 60 F254 glass plates).
Magnolia officinalis was also analyzed for alkaloids according to the Japanese Pharmacopoeia, 16th Edition (1996), using HPTLC-MS (Camag TLC-MS interface). Standards of aristolochic acid mixtures of AAI and AAII (HPLC purity: 98.7%; Acros Organics) were purchased from Thermo Fisher Scientific (Geel, Belgium). Magnolol (HPLC purity: 100.0%) and honokiol (HPLC purity: 100.0%) were purchased from Extrasynthèse (Genay, France). Magnoflorine was purchased from Sigma-Aldrich (reference SMB00377).

5.3. Cell Culture of HK-2 Kidney Proximal Human Tubule Cells

HK-2 cells, originating from human RPTECs, were obtained from American Type Culture Collection (CRL-2190, ATCC, Manassas, VA, USA), and grown in low-glucose DMEM containing 10% fetal bovine serum (FBS PAA Clone, PAA laboratories, Pasching, Austria), 2 mM L-glutamine, and 1% penicillin-streptomycin. Cells were sub-cultured or harvested for experiments when reaching about 90% confluence. For experimental purposes, cells were used between Passage 6 and 25, harvested by trypsinization, and seeded on 12-well plates (1 × 105 cells), 8-well chambered slides (Lab-Tek II, Nunc, Rochester, NY, USA) (2 × 104 cells), or 96-well plates (1 × 104 cells). Next, cells were incubated for 24 h in an FBS-containing medium, rinsed twice with DMEM, and treated with test substances at a concentration from 0.0625 to 16 mg/mL in an FBS-depleted medium.
Preliminary cytotoxicity assays were performed by Bunel et al. [12] to determine the working doses of each compound. Based on their recognized cytotoxicity in vivo, AA was used at IC25 (≈50 µM); maximum concentrations of magnolol and honokiol were the highest non-lethal doses (10 µM).
Aristolochic acids were a 50:50 mixture of AAI and AAII (HPLC purity: 98.7%; Acros Organics, Thermo Fisher Scientific, Geel, Belgium). Magnolol (HPLC purity: 100.0%) and honokiol (HPLC purity: 100.0%) were purchased from Extrasynthèse (Genay, France). Magnoflorine was purchased from Sigma-Aldrich (reference SMB00377).

5.4. Cell Viability Assay by a Resazurin Assay

As described by Bunel et al. [12], wells were treated with test compounds in 96-well plates, washed twice with PBS, and assessed for their viability (metabolic activity) by incubation with 0.44 mM resazurin solution (Sigma-Aldrich, St. Louis, MI, USA) for 1.5 h at 37 °C. Absorbances were measured at wavelengths 540 and 620 nm and percentages of reduced dye were calculated with the following formula:
ε OX λ 2 · A λ 1 ε OX λ 1 · A λ 2 ε RED λ 1 · A λ 2 ε RED λ 2 · A λ 1
where εOX is the molar extinction coefficient of resazurin (47.6 at 540 nm and 34.8 at 620 nm); εRED is the molar extinction coefficient of resorufin (104.4 at 540 nm and 5.5 at 620 nm); A is the absorbance of the test wells; A’ is the mean absorbance of the blank wells; λ1 = 540 nm; λ2 = 620 nm. Metabolic activity was normalized against the control condition.
Absorbances were measured with an iEMS Reader MF spectrophotometer (Thermo Labsystems, Breda, The Netherlands). The positive control (bleomycin, 0.8 to 200 µg/mL) or negative control (supplemented medium) was added.

5.5. IF 96-Well on the HK-2 Kidney Cell Line

Cells were seeded in 96-well plates (10,000 cells per well) and grown at 37 °C for 24 h before plant extracts, AA, lignans (both or separately), magnoflorine, or a positive (bleomycin, 200 µg/mL) or negative control (supplemented medium) were added.
After 24 h or 48 h, the cells were washed with PBS for 5 min, fixed with 100 µL/well of 4% PFA for 20 min, washed 4 times consecutively with tap water, distilled water, PBS with triton (0.01%), and PBS alone (100 µL/well) for 5 min. The cells were incubated overnight at 4 °C with 100 µL/well of a 1/1000 dilution of the anti-γ-H2AX primary antibody (goat anti-serum, 20%) for 1 h at room temperature. The cells were washed with 100 µL/well PBS twice. Cells were then incubated overnight on a mild rotative shaker at 4 °C with 30 µL/well of a 1/1000 dilution of the DyLight 488 conjugated secondary antibody (Mouse Phospho-Histone H2A.X pSer140 Antibody (3F2)-species reactivity: mouse, human, and bovine, Thermo Scientific®® ref MA1-2022) in goat serum, washed with PBS twice for 5 min (100 µL/well).
Work henceforth progressed in the dark. Cells were mounted using a few microliters of ProLong mounting medium with DAPI. A coverslip was added (Cover Glasses, 6 mm diameter, thickness n.0 VWR-Cat. 631-0168), and plates were recovered by adhesive film for microplates (VWR-Ref. 391-1254). Plates were conserved in aluminum at 4 °C.
The fluorescence was quantified using a microscope Axio Observer Z.1 (Zeiss) and Image J.

5.6. Bacterial Reverse Mutation Test or Ames Test

An Ames test was run using five strains of histidine-deficient Salmonella typhimurium—TA-100, TA-98, TA-1535, and TA-1537—with and without the liver S9 fraction. This liver S9 fraction is used to imitate mammalian metabolism [26]. The Ames test is one of the most frequently applied tests in toxicology. Almost all new pharmaceutical substances and chemicals used in industry are tested by this assay. Each herbal extract was tested on four different strains. TA100 and TA1535 were used to detect base substitution mutations, and TA98 and TA1537 were used to detect frameshift mutations. This strain was purchased from Xenometrix (Anaria) (Ames MPFTM 98/100/1535/1537 kit). The positive controls used were 2-nitrofluorene (2 µg/mL, Xenometrix® (AA01-410)), N4-aminocytidine (100 µg/mL, Xenometrix®), 4-nitroquinoline-N-oxide (0.1 µg/mL, Xenometrix®), and 9-aminocridine (15 µg/mL, Xenometrix®) (Table 5).
Sample concentrations assayed were from 0.05 to 10 mg/mL. The mutagenic effect of different herbal extracts was assessed after 48 h of incubation with the 4 strains (TA98, TA100, TA1535, and TA1537) in triplicate, with and without the S9 fraction.
A t-test was performed (p-values, 1-sided, based on unpaired data). The level of significance was p ≤ 0.05.

6. Statistical Analysis

Statistical analysis was performed with GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA). A probability level of p < 0.05 was considered significant.

Author Contributions

Conceptualization, M.P.; methodology, M.P., A.A., K.K. and A.N.S.; software, M.P. and L.T.; validation, M.P.; formal analysis, M.P.; investigation, M.P.; writing—original draft preparation, M.P.; writing—review and editing, M.P., A.N.S., J.N. and P.D.; visualization, J.N., M.-H.A., A.N. and P.D.; supervision, J.N. and P.D.; project administration, J.N. and P.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This research was supported by the Laboratory of Experimental Nephrology (Université Libre de Bruxelles), University of Mons and Saint-Petersburg Institute of Pharmacy. The help of Eric Raspé is kindly acknowledged. Confocal microscopy was performed at the CMMI. The CMMI is supported by the European Regional Development Fund and the Walloon Region. Valery Makarov is acknowledged for the access to the facilities.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Das, S.; Thakur, S.; Korenjak, M.; Sidorenko, V.S.; Chung, F.F.; Zavadil, J. Aristolochic acid-associated cancers: A public health risk in need of global action. Nat. Rev. Cancer 2022, 22, 576–591. [Google Scholar] [CrossRef] [PubMed]
  2. Holanda, D.M.; Yiannikouris, A.; Kim, S.W. Investigation of the Efficacy of a Postbiotic Yeast Cell Wall-Based Blend on Newly-Weaned Pigs under a Dietary Challenge of Multiple Mycotoxins with Emphasis on Deoxynivalenol. Toxins 2020, 12, 504. [Google Scholar] [CrossRef] [PubMed]
  3. Gruber-Dorninger, C.; Jenkins, T.; Schatzmayr, G. Global mycotoxin occurrence in feed: A ten-year survey. Toxins 2019, 11, 375. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Poivre, M.; Nachtergael, A.; Bunel, V.; Okusa, P.; Duez, P. Chapter 9: Genotoxicity and Carcinogenicity of Herbal Products. In Toxicology of Herbal Products; Pelkonen, O., Duez, P., Vuorela, P., Vuorela, H., Eds.; Springer: Cham, Switzerland, 2017; pp. 179–215. [Google Scholar]
  5. Jing, Y.J.; Ni, J.W.; Ding, F.H.; Fang, Y.H.; Wang, X.Q.; Wang, H.B.; Chen, X.N.; Chen, N.; Zhan, W.W.; Lu, L.; et al. p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE−/− mice. Kidney Int. 2016, 89, 439–449. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Cunha, R.S.D.; Santos, A.F.; Barreto, F.C.; Stinghen, A.E.M. How do uremic toxins affect the endothelium? Toxins 2020, 12, 412. [Google Scholar] [CrossRef]
  7. Vanherweghem, J.L.; Tielemans, C.; Abramowicz, D.; Depierreux, M.; Vanhaelen-Fastre, R.; Vanhaelen, M.; Jadoul, M. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993, 341, 387–391. [Google Scholar] [CrossRef]
  8. Depierreux, M.; Van Damme, B.; Houte, K.V.; Vanherweghem, J.L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. AJKD 1994, 24, 172–180. [Google Scholar] [CrossRef]
  9. Jadot, I.; Declèves, A.E.; Nortier, J.; Caron, N. An integrated view of aristolochic acid nephropathy: Update of the literature. Int. J. Mol. Sci. 2017, 18, 297. [Google Scholar] [CrossRef] [Green Version]
  10. Vanhaelen, M.; Vanhaelen-Fastre, R.; But, P.; Vanherweghem, J.-L. Identification of aristolochic acid in Chinese herbs. Lancet 1994, 343, 174. [Google Scholar] [CrossRef]
  11. Kang, Y.C.; Chen, M.H.; Lin, C.Y.; Lin, C.Y.; Chen, Y.T. Aristolochic acid-associated urinary tract cancers: An updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies. Ther. Adv. Drug Saf. 2021, 12, 2042098621997727. [Google Scholar] [CrossRef]
  12. Bunel, V.; Souard, F.; Antoine, M.H.; Stévigny, C.; Nortier, J. Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins. Comprehensive Toxicology, 3rd ed.; Rath, T., Ed.; IntechOpen: London, UK, 2018; Volume 14, pp. 340–379. [Google Scholar]
  13. Anttila, A.; Bhat, R.V.; Bond, J.A.; Borghoff, S.J.; Bosch, F.X.; Carlson, G.P.; Castegnaro, M.; Cruzan, G.; Gelderblom, W.C.; Hass, U.; et al. IARC monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC Press: Lyon, France, 2002; Volume 82, pp. 69–129. [Google Scholar]
  14. Bara, T., Jr.; Gurzu, S.; Sugimura, H.; Bara, T.; Beleaua, M.A.; Jung, I. A systematic review of the possible carcinogenic role of the aristolochic acid. Rom. J. Morphol. Embryol. 2017, 58, 41–44. [Google Scholar] [PubMed]
  15. Debelle, F.D.; Vanherweghem, J.L.; Nortier, J.L. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008, 74, 158–169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Jelaković, B.; Dika, Ž.; Arlt, V.M.; Stiborova, M.; Pavlović, N.M.; Nikolić, J.; Colet, J.M.; Vanherweghem, J.L.; Nortier, J.L. Balkan endemic nephropathy and the causative role of aristolochic acid. J. Sem. Nephrol. 2019, 39, 284–296. [Google Scholar] [CrossRef] [PubMed]
  17. Zhang, J.; Chan, C.K.; Ham, Y.H.; Chan, W. Identifying Cysteine, N-Acetylcysteine, and Glutathione-Conjugates as Novel Metabolites of Aristolochic Acid I: Emergence of a New Detoxification Pathway. Chem. Res. Toxicol. 2020, 33, 1374–1381. [Google Scholar] [CrossRef] [PubMed]
  18. Nachtergael, A.; Poivre, M.; Belayew, A.; Duez, P. In vitro genotoxicity tests point to an unexpected and harmful effect of a Magnolia and Aristolochia association. J. Ethnopharmacol. 2015, 174, 178–186. [Google Scholar] [CrossRef] [PubMed]
  19. Kong, Z.L.; Tzeng, S.C.; Liu, Y.C. Cytotoxic neolignans: An SAR study. Bioorg. Med. Chem. Lett. 2005, 15, 163–166. [Google Scholar] [CrossRef] [PubMed]
  20. Poivre, M.; Duez, P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J. Zhejiang Univ. Sci. B 2017, 18, 194–214. [Google Scholar] [PubMed] [Green Version]
  21. Yan, R.; Wang, W.; Guo, J.; Liu, H.; Zhang, J.; Yang, B. Studies on the Alkaloids of the Bark of Magnolia officinalis: Isolation and On-line Analysis by HPLC-ESI-MSn. Molecules 2013, 18, 7739–7750. [Google Scholar] [CrossRef] [Green Version]
  22. Guo, Z.F.; Wang, X.B.; Luo, J.G.; Luo, J.; Wang, J.S.; Kong, L.Y. A novel aporphine alkaloid from Magnolia officinalis. Fitoterapia 2011, 82, 637–641. [Google Scholar] [CrossRef]
  23. Dharmananda, S. Safety Issues Affecting Chinese Herbs: Magnolia Alkaloids; Institute for Traditional Medicine: Portland, OR, USA, 2002; Available online: http://www.itmonline.org/arts/magsafe.htm (accessed on 15 November 2022).
  24. Kuo, L.J.; Yang, L.X. γ-H2AX-a novel biomarker for DNA double-strand breaks. In Vivo 2008, 22, 305–309. [Google Scholar]
  25. Valdiglesias, V.; Giunta, S.; Fenech, M.; Neri, M.; Bonassi, S. γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat. Res. 2013, 753, 24–40. [Google Scholar] [CrossRef] [PubMed]
  26. Alonso-Jauregui, M.; González-Peñas, E.; López de Cerain, A.; Vettorazzi, A. Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction. Toxins 2022, 14, 400. [Google Scholar] [CrossRef] [PubMed]
  27. Estevez, P.; Sibat, M.; Leão-Martins, J.M.; Tudó, A.; Rambla-Alegre, M.; Aligizaki, K.; Diogène, J.; Gago-Martinez, A.; Hess, P. Use of Mass Spectrometry to Determine the Diversity of Toxins Produced by Gambierdiscus and Fukuyoa Species from Balearic Islands and Crete (Mediterranean Sea) and the Canary Islands (Northeast Atlantic). Toxins 2020, 12, 305. [Google Scholar] [CrossRef] [PubMed]
  28. Xue, L.; Zhang, J.; Shen, H.; Ai, L.; Wu, R. A randomized controlled pilot study of the effectiveness of magnolia tea on alleviating depression in postnatal women. Int. J. Food Sci. Nutr. 2020, 8, 1554–1561. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Najafi, M.B.H.; Pezeshki, P. Bacterial mutation; types, mechanisms and mutant detection methods: A review. Eur. Sci. J. 2013, 4, 1857–7431. [Google Scholar]
  30. OECD. Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines; Genetic Toxicology Guidance Document; OECD: Paris, France, 31 August 2015. [Google Scholar]
  31. Maron, D.M.; Ames, B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113, 173–215. [Google Scholar] [CrossRef]
  32. Liman, R.; Akyıl, D.; Eren, Y.; Konuk, M. Testing of the mutagenicity and genotoxicity of metolcarb by using both Ames/Salmonella and Allium test. Chemosphere 2010, 80, 1056–1061. [Google Scholar] [CrossRef]
  33. Rédei, G.P. Encyclopedia of Genetics, Genomics, Proteomics, and Informatics; Springer Science & Business Media: Dordrecht, The Netherlands, 2008. [Google Scholar]
  34. Stiborová, M.; Mareîs, J.; Frei, E.; Arlt, V.M.; Martínek, V.; Schmeiser, H.H. The human carcinogen aristolochic acid I is activated to form DNA adducts by human NAD (P) H: Quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases. Environ. Mol. Mutagen. 2011, 52, 448–459. [Google Scholar] [CrossRef]
  35. Sidorenko, V.S.; Attaluri, S.; Zaitseva, I.; Iden, C.R.; Dickman, K.G.; Johnson, F.; Grollman, A.P. Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 2014, 35, 1814–1822. [Google Scholar] [CrossRef] [Green Version]
  36. Afaq, F. Natural agents: Cellular and molecular mechanisms of photoprotection. Arch. Biochem. Biophys. 2011, 508, 144–151. [Google Scholar] [CrossRef] [Green Version]
  37. Hazra, B.; Ghosh, S.; Kumar, A.; Pandey, B.N. The prospective role of plant products in radiotherapy of cancer: A current overview. Front. Pharmacol. 2012, 2, 94. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Cui, W.; Wang, Y.; Chen, Q.; Sun, W.; Cai, L.; Tan, Y.; Kim, K.S.; Kim, K.H.; Kim, Y.H. Magnolia extract (BL153) ameliorates kidney damage in a high fat diet-induced obesity mouse model. Oxid. Med. Cell. Longev. 2013, 2013, 367040. [Google Scholar] [CrossRef] [PubMed]
  39. Au, C.K.; Chan, C.K.; Tung, K.K.; Zhang, J.; Chan, W. Quantitation of DNA Adducts of Aristolochic Acids in Repair-Deficient Cells: A Mechanistic Study of the DNA Repair Mechanism. Chem. Res. Toxicol. 2020, 33, 1323–1327. [Google Scholar] [CrossRef] [PubMed]
  40. Bensky, D.; Clavey, S.; Stõger, E. Materia Medica—Chinese Herbal Medicine, 3rd ed.; Eastland Press: Seattle, WA, USA, 2004; pp. 3–6. [Google Scholar]
  41. Mudie, D.M.; Murray, K.; Hoad, C.L.; Pritchard, S.E.; Garnett, M.C.; Amidon, G.L.; Gowland, P.A.; Spiller, R.C.; Amidon, G.E.; Marciani, L. Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State. Mol. Pharm. 2014, 11, 3039–3047. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Resazurin assay for HK-2 cell survival evaluation after incubation for 24 h and 48 h with methanolic or aqueous extracts of Aristolochia baetica or Magnolia officinalis, respectively, alone or in combination (means +/− SD from three separate experiments in duplicate (n = 6)).
Figure 1. Resazurin assay for HK-2 cell survival evaluation after incubation for 24 h and 48 h with methanolic or aqueous extracts of Aristolochia baetica or Magnolia officinalis, respectively, alone or in combination (means +/− SD from three separate experiments in duplicate (n = 6)).
Toxins 15 00052 g001
Figure 2. Representative immunofluorescence images obtained from control HK-2 cells and cells exposed for over 24 h to aqueous plant extracts alone or in combination, and to 200 µg/mL bleomycin (20x magnification, 1 cm = 500 µm, n = 4).
Figure 2. Representative immunofluorescence images obtained from control HK-2 cells and cells exposed for over 24 h to aqueous plant extracts alone or in combination, and to 200 µg/mL bleomycin (20x magnification, 1 cm = 500 µm, n = 4).
Toxins 15 00052 g002
Figure 3. (A) Total fluorescence (RFU) and (B) total fluorescence per nucleus (RFU) after 24 h of HK-2 cells exposure (n = 4) to aqueous extracts of Aristolochia (1 mg/mL), Magnolia (1 mg/mL), and a Aristolochia–Magnolia combination at the same concentration (1:1 ratio), respectively. Each analysis corresponds to the 3000 microscope fields counted. A one-way ANOVA test was followed by Dunnett’s multiple comparison test with the control. ns: not significant vs. negative control. ** p < 0.01; *** p < 0.001.
Figure 3. (A) Total fluorescence (RFU) and (B) total fluorescence per nucleus (RFU) after 24 h of HK-2 cells exposure (n = 4) to aqueous extracts of Aristolochia (1 mg/mL), Magnolia (1 mg/mL), and a Aristolochia–Magnolia combination at the same concentration (1:1 ratio), respectively. Each analysis corresponds to the 3000 microscope fields counted. A one-way ANOVA test was followed by Dunnett’s multiple comparison test with the control. ns: not significant vs. negative control. ** p < 0.01; *** p < 0.001.
Toxins 15 00052 g003aToxins 15 00052 g003b
Figure 4. Mean fluorescence per nucleus of γH2AX after 24 h of HK-2 cell exposure (n = 3). The negative control represents untreated cells. Bleomycin is the positive control.
Figure 4. Mean fluorescence per nucleus of γH2AX after 24 h of HK-2 cell exposure (n = 3). The negative control represents untreated cells. Bleomycin is the positive control.
Toxins 15 00052 g004
Table 1. Alkaloids (mainly benzylisoquinoleine alkaloids) and lignans detected in barkaqueous and methanolic extracts of M. officinalis, respectively, by the TLC-MS negative ESI mode for lignan detection and the positive ESI mode for alkaloid detection.
Table 1. Alkaloids (mainly benzylisoquinoleine alkaloids) and lignans detected in barkaqueous and methanolic extracts of M. officinalis, respectively, by the TLC-MS negative ESI mode for lignan detection and the positive ESI mode for alkaloid detection.
MoleculesMS Detection
(m/z)
Aqueous ExtractMethanolic Extract
Alkaloids
Anaxagoreine284 (M + H) +
283 + D +
yesyes
Asimilobine268 (M + H) +yesno
(S)-4-Kétomagnoflorine356 (M) +yesyes
Corytuberine328 (M) +yesyes
1,9,10-Trihydroxy-2-méthoxy-6,6-diméthylaporphinium
Liriodénine276 (M + H) +yesyes
Lotusine314 (M) +yesyes
(R)-Magnocurarine
(R)-Oblongine
(S)-Magnoflorine342 (M) +yesyes
N-Méthylcoclaurine300 (M + H) +yesyes
Remerine315 (M + H) +yesyes
Réticuline330 (M + H) +yesyes
(S)-Tembetarine344 (M) +yesyes
Lignans
Magnolol265 (M + H) yesyes
Honokiol265 (M + H) yesyes
Table 2. Cell viability was determined by the resazurin assay on HK-2 cells. Curves have been fitted to the data from three separate experiments (n = 6) and have been fitted with nonlinear regression (log(inhibitor) vs. normalized response—variable slope).
Table 2. Cell viability was determined by the resazurin assay on HK-2 cells. Curves have been fitted to the data from three separate experiments (n = 6) and have been fitted with nonlinear regression (log(inhibitor) vs. normalized response—variable slope).
Resazurin Assay and IC50
Aqueous ExtractsMethanolic Extracts
After 24 hAfter 48 hAfter 24 hAfter 48 h
Aristolochia baetica4.8 mg/mL1.7 mg/mL0.3 mg/mL0.3 mg/mL
Magnolia officinalis0.7 mg/mL0.2 mg/mL0.5 mg/mL0.5 mg/mL
Aristolochia–Magnolia (1:1)0.7 mg/mL0.2 mg/mL0.2 mg/mL0.1 mg/mL
Table 3. Results of the Ames tests performed on Salmonella typhimurium strains TA-98 and TA-100 with and without the S9 fraction, after exposure to aqueous extracts of Aristolochia, Magnolia, or a combination of both plants. Baseline = Mean ± 1 SD. A t-test was performed (p-values, 1-sided, based on unpaired data). Level of significance: p ≤ 0.05 (n = 3). Values ≥ 2.0 are considered to be positive (mutagenic).
Table 3. Results of the Ames tests performed on Salmonella typhimurium strains TA-98 and TA-100 with and without the S9 fraction, after exposure to aqueous extracts of Aristolochia, Magnolia, or a combination of both plants. Baseline = Mean ± 1 SD. A t-test was performed (p-values, 1-sided, based on unpaired data). Level of significance: p ≤ 0.05 (n = 3). Values ≥ 2.0 are considered to be positive (mutagenic).
Dose (mg/mL)BaselineFold Increase over the BaselineSignificant Increase Compared to Concurrent Vehicle Control (t-test)
TA-98 strain
Aristolochia—S9 activation
01.24
100.800.3217
53.480.0212
12.410.0124
0.51.610.0581
0.251.070.1151
0.050.270.2593
Magnolia—S9 activation
05.55
100.240.2383
50.660.3120
11.140.0745
0.51.080.1072
0.250.660.3036
0.050.360.3744
Aristolochia–Magnolia combination—S9 activation
01.24
104.290.0300
53.750.0163
15.090.0095
0.52.140.0066
0.250.540.5000
0.051.610.0581
TA-100 strain
Aristolochia—S9 activation
04.00
102.170.0029
51.670.0127
11.330.0286
0.50.750.5000
0.250.580.3351
0.050.920.2459
Aristolochia—Without S9 activation
01.91
103.840.0016
53.660.0000
12.440.0121
0.52.270.0079
0.251.920.0176
0.050.520.3217
Table 4. Aqueous and methanolic extraction yields.
Table 4. Aqueous and methanolic extraction yields.
PlantsPicturesAqueous Decoction Time
(min)
Lyophilization YieldsMethanolic Extraction Yields
Magnolia officinalis Rehder & E.H. Wilson CortexToxins 15 00052 i001151.5%12.1%
Aristolochia baetica L. RadixToxins 15 00052 i0024523.4%23.5%
Table 5. Salmonella thyphimurium strains and parameters detected by the Ames test.
Table 5. Salmonella thyphimurium strains and parameters detected by the Ames test.
StrainMutationMutation DetectedTargetPositive Control
TA98hisD3052FrameshiftsGCGCGCGC2-nitrofluorene
(2-NF)
TA100hisG46Base–pair substitutionGGG4-nitroquinoline N-oxide (4-NQO)
TA1535hisG46Base–pair substitutionGGGN4-aminocytidine (N4-ACT)
TA1537hisC3076Frameshifts+1 frameshift (near C-C-C run)9-aminocridine (9AA)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Poivre, M.; Antoine, M.-H.; Kryshen, K.; Atsapkina, A.; Shikov, A.N.; Twyffels, L.; Nachtergael, A.; Duez, P.; Nortier, J. Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis. Toxins 2023, 15, 52. https://doi.org/10.3390/toxins15010052

AMA Style

Poivre M, Antoine M-H, Kryshen K, Atsapkina A, Shikov AN, Twyffels L, Nachtergael A, Duez P, Nortier J. Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis. Toxins. 2023; 15(1):52. https://doi.org/10.3390/toxins15010052

Chicago/Turabian Style

Poivre, Mélanie, Marie-Hélène Antoine, Kirill Kryshen, Anastasia Atsapkina, Alexander N. Shikov, Laure Twyffels, Amandine Nachtergael, Pierre Duez, and Joëlle Nortier. 2023. "Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis" Toxins 15, no. 1: 52. https://doi.org/10.3390/toxins15010052

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop